[2024年和2025年皮肤病学热点话题]。

Q4 Medicine

Revue medicale suisse Pub Date : 2025-03-26 DOI:10.53738/REVMED.2025.21.911.606

David Alvarez Martinez, Gürkan Kaya

{"title":"[2024年和2025年皮肤病学热点话题]。","authors":"David Alvarez Martinez, Gürkan Kaya","doi":"10.53738/REVMED.2025.21.911.606","DOIUrl":null,"url":null,"abstract":"Dermatology has made significant advances in recent years. Ruxolitinib cream offers new hope for vitiligo, though reimbursement remains uncertain. A consensus now standardizes the management of Drug Reaction with Eosinophilia and Systemic Symptoms, while IL-26 emerges as a promising target in pustular psoriasis. Concerns about a potential link between dupilumab and cutaneous T-cell lymphoma call for increased clinical vigilance. Meanwhile, bimekizumab marks a breakthrough in hidradenitis suppurativa treatment. Addressing Trichophyton indotineae resistance requires complex strategies. Finally, innovative laser targeting sebaceous glands offers new hope for acne.","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 911","pages":"606-610"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Hot Topics 2024 and 2025 in dermatology].\",\"authors\":\"David Alvarez Martinez, Gürkan Kaya\",\"doi\":\"10.53738/REVMED.2025.21.911.606\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dermatology has made significant advances in recent years. Ruxolitinib cream offers new hope for vitiligo, though reimbursement remains uncertain. A consensus now standardizes the management of Drug Reaction with Eosinophilia and Systemic Symptoms, while IL-26 emerges as a promising target in pustular psoriasis. Concerns about a potential link between dupilumab and cutaneous T-cell lymphoma call for increased clinical vigilance. Meanwhile, bimekizumab marks a breakthrough in hidradenitis suppurativa treatment. Addressing Trichophyton indotineae resistance requires complex strategies. Finally, innovative laser targeting sebaceous glands offers new hope for acne.\",\"PeriodicalId\":21286,\"journal\":{\"name\":\"Revue medicale suisse\",\"volume\":\"21 911\",\"pages\":\"606-610\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue medicale suisse\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53738/REVMED.2025.21.911.606\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale suisse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53738/REVMED.2025.21.911.606","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

皮肤病学近年来取得了重大进展。Ruxolitinib霜为白癜风提供了新的希望，尽管报销仍不确定。目前，对嗜酸性粒细胞增多和全身症状的药物反应管理已达成共识，而IL-26则成为脓疱性银屑病的一个有希望的靶点。对dupilumab与皮肤t细胞淋巴瘤之间潜在联系的担忧要求提高临床警惕性。同时，比美珠单抗标志着化脓性汗腺炎治疗的突破。解决毛癣菌的耐药问题需要复杂的策略。最后，创新激光瞄准皮脂腺为痤疮提供了新的希望。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[Hot Topics 2024 and 2025 in dermatology].

Dermatology has made significant advances in recent years. Ruxolitinib cream offers new hope for vitiligo, though reimbursement remains uncertain. A consensus now standardizes the management of Drug Reaction with Eosinophilia and Systemic Symptoms, while IL-26 emerges as a promising target in pustular psoriasis. Concerns about a potential link between dupilumab and cutaneous T-cell lymphoma call for increased clinical vigilance. Meanwhile, bimekizumab marks a breakthrough in hidradenitis suppurativa treatment. Addressing Trichophyton indotineae resistance requires complex strategies. Finally, innovative laser targeting sebaceous glands offers new hope for acne.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revue medicale suisse Medicine-Medicine (all)

CiteScore

0.60

自引率

0.00%

发文量

1210

期刊介绍： Destinée aux professionnels de santé, la plateforme revmed.ch regroupe la version électronique de la Revue Médicale Suisse et les applications de formation et d"aide à la prise de décision eRMS. La eRMS est le fruit d’une large collaboration entre institutions et praticiens de Suisse romande.